Donald J. Kellerman, VP, Clinical Development & Med Affairs at Zosano Pharma Corp (ZSAN), bought 15,920 shares at $1.32 ($21K) on 2016-08-19, disclosed to the SEC on 2016-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| MAPP | SELL | 2013-02-04 | $35K | — | Filing → |